Moreover, the analysis of GEO drug discovery showed that methotrexate could significantly decrease the expression of XIST in patients with juvenile idiopathic arthritis with an FDR < 0.05 (Fig. 8B). The gene discussed is XIST; the disease is juvenile idiopathic arthritis.